Public Sector Network Tender Alert


PO 6073 - Independent Evaluation of the replacement of malaria monotherapy drugs in the private sector to support the containment of drug resistant malaria in Burma

The new generation of malaria drugs, artemisinin combination therapies (ACTs) provide a highly effective cure for the most dangerous malaria in most countries; helping to reduce the global burden of malaria by more than half in 43 countries over the past 10 years. This global progress is now threatened by the emergence of malaria that shows resistance to artemisinin. Artemisinin resistant malaria, first detected on the Thai-Cambodia border and then Vietnam, now occurs in eastern Burma. In response, Burma has developed the Myanmar Artemisinin Resistance Containment Framework (referred to as ‘MARC’), with support from the Ministry of Health and key non-governmental implementing partners of malaria control. The MARC comprises a comprehensive set of interventions from prevention of malaria and testing and treatment with ACTs. The MARC prioritises five complementary areas for interventions: community-based malaria diagnosis and treatment; replacement of oral artemisinin monotherapy (AMT) in the private sector; a legal ban of AMT; insecticide treated bed nets and screening and malaria treatment for mobile populations. This strategy is in line with the World Health Organization’s Global Plan for Artemisinin Resistance Containment (GPARC) . Routine monitoring is outside the scope of the services required from the IEA. PSI have included the full costs of monitoring in their programme. They will establish clear baseline data, monitor progress against milestones and targets in the Log Frame and provide progress and annual reports. This includes the use of routine data collection systems and surveys to monitor the programme. The Independent Evaluation Agency will be required to assess that the baseline data is relevant and adequate and that data collection tools and methods (particularly surveys) to ensure this routine information can support data requirements for programme evaluation.

Ref: DFID 6073,


Contract value: 0.01GBP

Published: 21 Dec 2012, Receipt by: 21 Mar 2015